• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Study on Nalmefene, Naloxone for Fentanyl Respiratory Depression

    BUSINESSWIRE

    Harm Reduction Therapeutics Donates RiVive Naloxone on Overdose Awareness Day

    GLOBENEWSWIRE

    Hikma Participates In Naloxone Training With Congressman

    PR NEWSWIRE

    Medea Partners With CalOptima To Distribute Naloxone In Southern California

    BUSINESSWIRE

    This Must Be The Place And Walgreens Expand Naloxone Access

    BUSINESSWIRE

    Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution

    GLOBENEWSWIRE

    Emergent BioSolutions Launches Opioid Emergency Campaign With Emmitt Smith

    GLOBENEWSWIRE

    US FDA declines to approve Orexo`s opioid overdose drug

    REUTERS

    Emergent Drives Progress Against Opioid Epidemic On Naloxone Day

    GLOBENEWSWIRE

    Amneal Launches OTC Naloxone In US Retail, California

    BUSINESSWIRE

    Purdue Pharma partners with MMCAP Infuse to provide low-cost opioid use disorder

    PHARMABIZ

    Drugmaker Amneal agrees to $270 million U.S. opioid settlement

    REUTERS

    Amneal`s OTC Naloxone Nasal Spray Approved

    BUSINESSWIRE

    Amneal Pharm Generic Naloxone Hydrochloride Receives Approval in the U.S.

    FDA

    Fresenius Kabi USA Generic Naloxone Hydrochloride Receives Approval in the U.S.

    FDA

    Emergent Continues to Awareness and Availability of NARCAN® Nasal Spray

    GLOBENEWSWIRE

    Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making

    GLOBENEWSWIRE

    Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice

    PR NEWSWIRE

    Sun Pharma`s Generic Buprenorphine & Naloxone Hydrochloride Receives Approval in the U.S.

    FDA

    OTC naloxone to cost about as much as the brand-name, prescription version

    ENDPTS

    Orexo wins patent litigation for ZUBSOLV® in the US

    PR NEWSWIRE

    Enforcement Report - Week of June 7, 2023

    FDA

    Operation UNITE and HarborPath Awarded $1 Million Grant to Fund Naloxone-Plus

    BUSINESSWIRE

    FDA Confirms Paragraph IV Patent Litigation for Naloxone Hydrochloride

    FDA

    Heart to Heart CPR Now Offering Free Naloxone Kits and Opioid Response Training

    GLOBENEWSWIRE

    Emergent makes history with first FDA nod for over-the-counter naloxone

    FIERCE PHARMA

    Amphastar Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg

    ACCESSWIRE

    Amneal Announces FDA Filing Acceptance of NDA for Naloxone HCL Nasal Spray

    BUSINESSWIRE

    FDA expert panel unanimously backs over-the-counter Narcan nod

    FIERCE PHARMA

    Should Narcan spray be sold over counter? FDA poses potential packaging changes

    ENDPTS

    Orexo seeks approval of nasal high-dose opioid rescue medicine

    FIERCE PHARMA

    Harm Reduction Therapeutics` NDA for RiVive™ OTC Naloxone Nasal Spray

    PRNEWSWIRE

    U.S. FDA to review Emergent`s OTC opioid overdose drug on priority

    BIOSPACE

    Emergent Announces U.S. FDA Acceptance & Review of SNDA for OTC NARCANA

    GLOBENEWSWIRE

    Naloxone Startup Pursues FDA Approval for Over-the-Counter Swab

    WSJ

    NaxSwab OTC novel naloxone nasal swab demonstrates faster absorption

    PRNEWSWIRE

    FDA Announces that Naloxone Products Have Potential to be Safe for Counter Use

    PRNEWSWIRE

    Enforcement Report - Week of November 9, 2022

    FDA

    Baxter`s Generic Naloxone Hydrochloride Receives Approval in the U.S.

    FDA

    Accord`s Generic Cabazitaxel Receives Approval in the U.S.

    FDA

    Walmart to pay $215 million to settle Florida opioid claims

    FIRSTWORDPHARMA

    Naloxone Initiates a Rolling Submission of its NDA to U.S.FDA for RiVive

    PRNEWSWIRE

    FDA Issues New Guidance to Help Facilitate Availability of Naloxone to Opioid

    FDA

    FDA exempts naloxone distribution from DSCSA tracking requirements

    RAPS

    Naloxone Product Giving People Hope to Help Combat Growing Opioid Overdose Trend

    BUSINESSWIRE

    Indivior fails to escape class action lawsuit in Suboxone case

    ENDPTS

    Harm Reduction Therapeutics Signs Supply Agreement for Fast Tracked Naloxone

    PRNEWSWIRE

    Par Sterile Products Generic Naloxone HCL Receives Approval Approval in U.S.

    FDA

    HarborPath Selects FFF Enterprises as Exclusive Distributor for Naloxone

    BUSINESSWIRE

    Padagis Announces 3 Major Product Launches

    FDA

    Padagis`s Generic Naloxone Hydrochloride Receives Approval in US

    FDA

    Hikma Pharmaceuticals Generic Naloxone HCL Receives Approval in the U.S.

    FDA

    Mylan Labs Generic Naloxone Hydrochloride Receives Approval in the U.S.

    FDA

    Aveva`s Generic Buprenorphine HCL Naloxone HCL Receives Approval in the U.S.

    FDA

    Opiant Pharma Shows Topline Results Comparing Nasal Nalmefene to Nasal Naloxone

    GLOBENEWSWIRE

    A $2.1 million price tag for Bluebird Bio’s gene therapy is cost-effective

    STATNEWS

    Purdue shells out a little more cash for naloxone OTC nasal spray

    ENDPTS

    HRT to Receive Additional Funding for OTC Naloxone Nasal Spray

    BUSINESSWIRE

    FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for Weaponized Opioids

    BUSINESSWIRE

    Harm Reduction Tx Says Naloxone Nasal Spray Met Its Primary Endpoints in Phase 1

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.